Status:
COMPLETED
Understand the Association Between Peritoneal Dialysis Status and Gene Polymorphisms of VEGF and KDR
Lead Sponsor:
RenJi Hospital
Conditions:
Peritoneal Dialysis
Eligibility:
All Genders
Brief Summary
Peritoneal dialysis (PD) is an effective and successful way of renal replacement therapy. The initial transport status is related to distribution of blood vessels and micro inflammation state in perit...
Eligibility Criteria
Inclusion
- Patients are Han Chinese;
- Patients prepare for dialysis in our center, and start PD within 3 months after abdominal catheterization;
- Patients successfully complete the first peritoneal equilibration test(PET);
- Follow up regularly in our PD center.
Exclusion
- Patients from hemodialysis to peritoneal dialysis;
- Patients who need peritoneal dialysis due to transplant-renal loss;
Key Trial Info
Start Date :
May 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04888065
Start Date
May 10 2018
End Date
December 30 2020
Last Update
May 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji Hospital
Shanghai, Shanghai Municipality, China, 310115